Litcius/Paper detail

Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis

Mengzhu Zheng, Canrong Wu, Kaiyin Yang, Yueying Yang, Yang Liu, Suyu Gao, Qiqi Wang, Chen Li, Lixia Chen, Hua Li

2020Pharmacological Research99 citationsDOI

Topics & Concepts

HexokinaseGlycolysisCancer cellCancer researchCell growthIn vivoCancerGene knockdownChemistryApoptosisPharmacologyBiologyCell biologyBiochemistryEnzymeBiotechnologyGeneticsCancer, Hypoxia, and MetabolismMetabolism, Diabetes, and CancerPancreatic function and diabetes
Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis | Litcius